| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 2 | +100.00% | +4.54% | +3.52% | +1.02% | +1.02% | — |
| 14d | 2 | +100.00% | +6.98% | +3.65% | +3.33% | +3.33% | — |
| 30d | 2 | +100.00% | -2.25% | +4.20% | -6.44% | -6.44% | — |
| 60d | 2 | +100.00% | +8.05% | +7.32% | +0.73% | +0.73% | — |
| 90d | 2 | +100.00% | +11.53% | +8.44% | +3.09% | +3.09% | — |
| 180d | 2 | +100.00% | +46.12% | +10.41% | +35.70% | +35.70% | — |
| 1y | 2(1 pending) | +100.00% | +101.87% | +21.66% | +80.21% | +80.21% | — |
| 2y | 2(2 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| BHC BAUSCH HEALTH COMPANIES INC. | PURCHASEGRANT Stock grant | 45,871 | — | — | 95,210 | May 22, 2026 | May 26, 2026 ↗ | View → |
| BHC BAUSCH HEALTH COMPANIES INC. | SALE10b5-1 10b5-1 plan | 24,456 | $5.43 | $132.8K | 49,339 | May 19, 2026 | May 20, 2026 ↗ | View → |
| PCRX PACIRA BIOSCIENCES, INC. | PURCHASEGRANT Stock grant | 261,818 | — | — | 660,830.841 | Feb 11, 2026 | Feb 13, 2026 ↗ | View → |
| PCRX PACIRA BIOSCIENCES, INC. | SALE Chief Executive Officer | 41,488 | $20.54 | $852.2K | 399,012.841 | Jan 30, 2026 | Feb 3, 2026 ↗ | View → |
| PCRX PACIRA BIOSCIENCES, INC. | SALE Chief Executive Officer | 9,272 | $24.46 | $226.8K | 440,500.841 | Jan 2, 2026 | Jan 6, 2026 ↗ | View → |
| BHC BAUSCH HEALTH COMPANIES INC. | SALE | 15,912 | $7.66 | $121.9K | 73,795 | Aug 21, 2025 | Aug 22, 2025 ↗ | View → |
| BHC BAUSCH HEALTH COMPANIES INC. | PURCHASEGRANT Stock grant | 54,347 | — | — | 89,707 | May 16, 2025 | May 20, 2025 ↗ | View → |
| PCRX PACIRA BIOSCIENCES, INC. | PURCHASEGRANT Stock grant | 350,000 | — | — | 448,409 | Feb 1, 2025 | Feb 4, 2025 ↗ | View → |
| PCRX PACIRA BIOSCIENCES, INC. | SALE Chief Executive Officer | 9,375 | $18.33 | $171.8K | 98,409 | Jan 2, 2025 | Jan 6, 2025 ↗ | View → |
| PCRX PACIRA BIOSCIENCES, INC. | PURCHASE Chief Executive Officer | 8,264 | $12.10 | $100.0K | 107,784 | Aug 12, 2024 | Aug 13, 2024 ↗ | View → |
| BOLT BOLT BIOTHERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 22,000 | — | — | 22,000 | Jun 12, 2024 | Jun 14, 2024 ↗ | View → |
| BHC BAUSCH HEALTH COMPANIES INC. | PURCHASEGRANT Stock grant | 35,360 | — | — | 35,360 | May 17, 2024 | May 21, 2024 ↗ | View → |
| PCRX PACIRA BIOSCIENCES, INC. | PURCHASEGRANT Stock grant | 692,512 | — | — | 692,512 | Jan 3, 2024 | Jan 4, 2024 ↗ | View → |
| PCRX PACIRA BIOSCIENCES, INC. | PURCHASEGRANT Stock grant | 99,520 | — | — | 99,520 | Jan 2, 2024 | Jan 4, 2024 ↗ | View → |
| BOLT BOLT BIOTHERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 25,000 | — | — | 25,000 | Jun 12, 2023 | Jun 14, 2023 ↗ | View → |
| BOLT BOLT BIOTHERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 25,000 | — | — | 25,000 | Jun 10, 2022 | Jun 10, 2022 ↗ | View → |
| BOLT BOLT BIOTHERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 22,140 | — | — | 22,140 | Mar 24, 2022 | Mar 28, 2022 ↗ | View → |
| BOLT BOLT BIOTHERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 14,071 | — | — | 14,071 | Mar 24, 2022 | Mar 28, 2022 ↗ | View → |
| BOLT BOLT BIOTHERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 27,860 | — | — | 27,860 | Nov 17, 2021 | Nov 19, 2021 ↗ | View → |